Home
CYCCP
CYCCP News

Latest Cyclacel Pharmaceuticals Inc. (CYCCP) News on November 22, 2024

Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

7 days ago

Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations

Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds

GlobeNewswire

7 days ago

Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds

GlobeNewswire

8 days ago

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss

Zacks

9 days ago

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

GlobeNewswire

9 days ago

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule

GlobeNewswire

a month ago

Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule

Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

GlobeNewswire

a month ago

Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

GlobeNewswire

a month ago

Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

MT Newswires

a month ago

Cyclacel Pharmaceuticals Files for Offering of Shares, Warrants

MT Newswires

2 months ago

Cyclacel Completes Enrollment of Biomarker-Based Patients in Phase 2 Fadraciclib Study

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study

GlobeNewswire

2 months ago

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

3 months ago

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter

GlobeNewswire

3 months ago

Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter

Cyclacel Pharmaceuticals (CYCC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Zacks

3 months ago

Cyclacel Pharmaceuticals (CYCC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Cyclacel Pharmaceuticals Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

3 months ago

Cyclacel Pharmaceuticals Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q2 Loss, Misses Revenue Estimates

Zacks

3 months ago

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q2 Loss, Misses Revenue Estimates

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

GlobeNewswire

3 months ago

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results

Cyclacel Pharmaceuticals (CYCC) Upgraded to Strong Buy: Here's What You Should Know

Zacks

4 months ago

Cyclacel Pharmaceuticals (CYCC) Upgraded to Strong Buy: Here's What You Should Know

MT Newswires

5 months ago

Cyclacel Receives Notice of European Patent Grant for Plogosertib; Shares Rise

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions

GlobeNewswire

5 months ago

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions

All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy

Zacks

5 months ago

All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy

Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting

GlobeNewswire

6 months ago

Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting

Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib’s Potential as a Precision Medicine for Cancer

GlobeNewswire

6 months ago

Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib’s Potential as a Precision Medicine for Cancer

GuruFocus.com

6 months ago

Cyclacel Pharmaceuticals Inc (CYCC) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update

GlobeNewswire

6 months ago

Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

GlobeNewswire

7 months ago

Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

MT Newswires

7 months ago

Top Midday Gainers

Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

7 months ago

Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Is Expected To Breakeven In The Near Future

Simply Wall St.

7 months ago

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Is Expected To Breakeven In The Near Future

Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer

GlobeNewswire

8 months ago

Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2023 Earnings Call Transcript

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

8 months ago

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results

Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

GlobeNewswire

8 months ago

Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

GlobeNewswire

9 months ago

Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference

GlobeNewswire

9 months ago

Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference

Regeneron Earnings Beat Forecasts as Sales of Updated Eye Drug Raise Hopes

Barrons.com

10 months ago

Regeneron Earnings Beat Forecasts as Sales of Updated Eye Drug Raise Hopes

7/2024・Trifork adjusts outlook for 2023 financial results and reports strong performance in Trifork Labs

GlobeNewswire

10 months ago

7/2024・Trifork adjusts outlook for 2023 financial results and reports strong performance in Trifork Labs

Northline Seafoods Streamlines Processes From Catch to Customer With the Help of NorthScope ERP Software

ACCESSWIRE

10 months ago

Northline Seafoods Streamlines Processes From Catch to Customer With the Help of NorthScope ERP Software

Reuters

10 months ago

Biden's job approval drops to 38% as border worries rise - Reuters/Ipsos

A Massive Problem With Apple Stock Today

Motley Fool

10 months ago

A Massive Problem With Apple Stock Today

Prime Minister announces changes to the parliamentary secretary team

CNW Group

10 months ago

Prime Minister announces changes to the parliamentary secretary team

Pest Control Market Analysis Report 2023: Chemical, Mechanical, Biological, Software & Services, Sprays, Traps, Baits, Pellets, Powder - Global Forecast to 2028

GlobeNewswire

10 months ago

Pest Control Market Analysis Report 2023: Chemical, Mechanical, Biological, Software & Services, Sprays, Traps, Baits, Pellets, Powder - Global Forecast to 2028

Williams Increases Quarterly Cash Dividend by 6.1%

Business Wire

10 months ago

Williams Increases Quarterly Cash Dividend by 6.1%

Business Wire

10 months ago

Issue of Debt

Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer

GlobeNewswire

10 months ago

Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

Motley Fool

10 months ago

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

Battalion Oil Corporation Announces Operations and Financial Update

GlobeNewswire

10 months ago

Battalion Oil Corporation Announces Operations and Financial Update

Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™

GlobeNewswire

10 months ago

Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™

King Charles III spends third day in London hospital after prostate surgery

AFP

10 months ago

King Charles III spends third day in London hospital after prostate surgery

Girona take Liga lead back with win at Celta

AFP

10 months ago

Girona take Liga lead back with win at Celta

20 "Tech" Stocks Make Up Over 35% of the S&P 500. Here's What That Means for Your Portfolio.

Motley Fool

10 months ago

20 "Tech" Stocks Make Up Over 35% of the S&P 500. Here's What That Means for Your Portfolio.

IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial

Business Wire

10 months ago

IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial

Laser Photonics Receives Order From Ship Point Machine Company For CleanTech Laser Cleaning System

ACCESSWIRE

10 months ago

Laser Photonics Receives Order From Ship Point Machine Company For CleanTech Laser Cleaning System

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal

GlobeNewswire

10 months ago

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal

Gladstone Commercial Corporation Announces Monthly Cash Distributions for January, February and March 2024 and Earnings Release and Conference Call Dates for its Fourth Quarter Ended December 31, 2023

ACCESSWIRE

10 months ago

Gladstone Commercial Corporation Announces Monthly Cash Distributions for January, February and March 2024 and Earnings Release and Conference Call Dates for its Fourth Quarter Ended December 31, 2023

Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement

GlobeNewswire

10 months ago

Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement

Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference

Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024

GlobeNewswire

a year ago

Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024

Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

a year ago

Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules

Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions

GlobeNewswire

a year ago

Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical Study

GlobeNewswire

a year ago

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical Study

Cyclacel Pharmaceuticals Announces Reverse Stock Split

GlobeNewswire

a year ago

Cyclacel Pharmaceuticals Announces Reverse Stock Split

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination

GlobeNewswire

a year ago

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

GlobeNewswire

a year ago

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

News Direct

a year ago

Revolutionizing trucking safety: Cepton's LiDAR technology takes the wheel for semi safety

PureCycle Resumes Pellet Production at Ironton Purification Facility

ACCESSWIRE

a year ago

PureCycle Resumes Pellet Production at Ironton Purification Facility

Cumulus Media Taps Collin Jones to Lead Westwood One

GlobeNewswire

a year ago

Cumulus Media Taps Collin Jones to Lead Westwood One

News Direct

a year ago

Transformative tech: Cepton's Mitch Hourtienne talks future of LiDAR integration in vehicles

Yoshitsu Co., Ltd Announces the Launch of its U.S. Direct-Sale Store in Seattle’s University District

GlobeNewswire

a year ago

Yoshitsu Co., Ltd Announces the Launch of its U.S. Direct-Sale Store in Seattle’s University District

Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC

GlobeNewswire

a year ago

Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC

Precision BioSciences to Present at Hep-DART 2023

Business Wire

a year ago

Precision BioSciences to Present at Hep-DART 2023

Health Care Roundup: Market Talk

The Wall Street Journal

a year ago

Health Care Roundup: Market Talk

Downgrade: What You Need To Know About The Latest Hall of Fame Resort & Entertainment Company (NASDAQ:HOFV) Forecasts

Simply Wall St.

a year ago

Downgrade: What You Need To Know About The Latest Hall of Fame Resort & Entertainment Company (NASDAQ:HOFV) Forecasts

Precision Optics Receives Initial Purchase Order Against $1.4 Million Development Program

PR Newswire

a year ago

Precision Optics Receives Initial Purchase Order Against $1.4 Million Development Program

Great Elm Group, Inc. (NASDAQ:GEG) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Great Elm Group, Inc. (NASDAQ:GEG) Q1 2024 Earnings Call Transcript

Cepton, Inc. Reports Third Quarter 2023 Results

Business Wire

a year ago

Cepton, Inc. Reports Third Quarter 2023 Results

GuruFocus.com

a year ago

Great Elm Group Inc Reports Substantial Revenue Growth and Net Income Turnaround in Q1 Fiscal 2024

Associated Press Finance

a year ago

Great Elm: Fiscal Q1 Earnings Snapshot

Gulf Island Fabrication, Inc. (NASDAQ:GIFI) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Gulf Island Fabrication, Inc. (NASDAQ:GIFI) Q3 2023 Earnings Call Transcript

Best Value Stocks to Buy for November 6th

Zacks

a year ago

Best Value Stocks to Buy for November 6th

Paltalk to Host Third Quarter 2023 Earnings Results Conference Call on Tuesday, November 7, 2023 at 4:30 p.m. ET

GlobeNewswire

a year ago

Paltalk to Host Third Quarter 2023 Earnings Results Conference Call on Tuesday, November 7, 2023 at 4:30 p.m. ET

Share on Social Networks: